ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,317,000 | -25.3% | 58,600 | 0.0% | 0.29% | -25.3% |
| Q4 2017 | $1,764,000 | -20.1% | 58,600 | 0.0% | 0.39% | -24.7% |
| Q3 2017 | $2,207,000 | +35.1% | 58,600 | 0.0% | 0.52% | +26.0% |
| Q2 2017 | $1,634,000 | +117.0% | 58,600 | +167.6% | 0.41% | +91.6% |
| Q1 2017 | $753,000 | +81.4% | 21,900 | +52.1% | 0.22% | +48.3% |
| Q4 2016 | $415,000 | -9.4% | 14,400 | 0.0% | 0.14% | -12.7% |
| Q3 2016 | $458,000 | -1.9% | 14,400 | 0.0% | 0.17% | -6.2% |
| Q2 2016 | $467,000 | +15.9% | 14,400 | 0.0% | 0.18% | +30.1% |
| Q1 2016 | $403,000 | -21.4% | 14,400 | 0.0% | 0.14% | -24.9% |
| Q4 2015 | $513,000 | – | 14,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $887,684,000 | 7.26% |
| Avoro Capital Advisors LLC | 1,630,000 | $56,039,000 | 7.16% |
| ACUTA CAPITAL PARTNERS, LLC | 572,756 | $19,691,000 | 4.67% |
| HWG Holdings LP | 100,994 | $3,472,000 | 4.38% |
| HARVEY CAPITAL MANAGEMENT INC | 230,350 | $7,919,000 | 3.56% |
| SECTORAL ASSET MANAGEMENT INC | 671,113 | $23,073,000 | 2.70% |
| Palo Alto Investors LP | 1,590,430 | $54,679,000 | 2.58% |
| Ghost Tree Capital, LLC | 350,000 | $12,033,000 | 2.24% |
| GARRISON BRADFORD & ASSOCIATES INC | 72,550 | $2,494,000 | 2.20% |
| EMORY UNIVERSITY | 56,135 | $1,930,000 | 1.82% |